Free light chains kappa can differentiate between myelitis and noninflammatory myelopathy

OBJECTIVE: To test the hypothesis that the intrathecal synthesis of free light chain kappa (FLC-k) can be used as a CSF biomarker to differentiate patients with myelitis due to multiple sclerosis (MS), myelitis due to neuromyelitis optica spectrum disease (NMOSD), and noninflammatory myelopathy, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Süße, Marie, Feistner, Fritz, Grothe, Matthias, Nauck, Matthias, Dressel, Alexander, Hannich, Malte Johannes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524577/
https://www.ncbi.nlm.nih.gov/pubmed/32948648
http://dx.doi.org/10.1212/NXI.0000000000000892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524577/
https://www.ncbi.nlm.nih.gov/pubmed/32948648
http://dx.doi.org/10.1212/NXI.0000000000000892

Ejemplares similares